Google+ Followers [Join for FREE]

Tuesday, December 23, 2014

Hefty Price Tag on Viral Hep C "Cure".... do you have $85K?

FDA approves new hepatitis C combination treatment.

The Wall Street Journal (12/19, Loftus, Subscription Publication) reported that the FDA approved AbbVie Inc.’s new treatment for hepatitis C, called Viekira Pak, after clinical trials showed that more than 90% of people with the most common subtype of hepatitis C in the US, Genotype 1, were cured. Viekira Pak consists of three new medicines, paritaprevir, ombitasvir and dasabuvir, in addition to one older drug, ritonavir. The treatment regimen will reportedly cost $83,319 per patient for the standard 12-week treatment, which is below the price tags on either of Gilead Science Inc.’s hepatitis C treatments: Sovaldi (sofosbuvir) or Harvoni (ledipasvir and sofosbuvir), costing $84,000 and $94,500, respectively.


Hi-Dose Vitamin C IV infusions at about $100/infusion which has fewer side effects and likely better efficacy is a bargain price.  Twice weekly IV VIt C infusions for a few months w/ Liposomal on days not infused....  Human clinical case reports show cure (Dr. T. Levy reports in his book "Primal Panacea")... for more visit 

Source:  From AMA Morning Rounds...

No comments:

About Me

My photo
Charleston; Myrtle Beach, SC; Raleigh-Durham, NC; Orlando, FL, GA, NC, SC, VA, FL, United States